SCHEMBL2491903

SCHEMBL2491903

NC(CC(=O)NC1CC1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 9/20 0.42
GRIK2 Q13002 4/20 0.42
GRIA1 P42261 1/20 0.42
GRIA2 P42262 1/20 0.42
GRIA4 P48058 1/20 0.42
GRIK3 Q13003 1/20 0.42
GRIK5 Q16478 1/20 0.42
CYP3A4 P08684 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
RAB9A P51151 1/20 0.41
GRM1 Q13255 1/20 0.41
GRM2 Q14416 1/20 0.41
SLC1A3 P43003 2/20 0.40
SLC1A2 P43004 2/20 0.40
SLC1A1 P43005 2/20 0.40
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
SMYD3 Q9H7B4 2/20 0.39
SLC7A5 Q01650 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2237940 0.92 HPGD (0.50) GRIK1GRIK2GRIA1GRIA2GRIA4
SCHEMBL2237937 0.92 HPGD (0.50) GRIK1GRIK2GRIA1GRIA2GRIA4
SCHEMBL2237095 0.91 ALDH1A1 (0.53) GRIK1GRIK2CYP3A4HPGDCYP2C19
SCHEMBL2237105 0.91 ALDH1A1 (0.53) GRIK1GRIK2CYP3A4HPGDCYP2C19
SCHEMBL13584985 0.88 GRIK1 (0.37) GRIK1GRIK2GRIA1GRIA2GRIA4
SCHEMBL13584983 0.88 GRIK1 (0.37) GRIK1GRIK2GRIA1GRIA2GRIA4
SCHEMBL10132089 0.84 LMNA (0.44) CYP3A4HPGDCYP2C19RAB9AALDH1A1
SCHEMBL31370247 0.83 GRIK1 (0.39) GRIK1GRIK2GRIA1GRIA2GRIA4
SCHEMBL1768527 0.81 SMN1; SMN2 (0.50) GRIK1GRIK2GRIA1GRIA2GRIA4
SCHEMBL1768530 0.81 SMN1; SMN2 (0.50) GRIK1GRIK2GRIA1GRIA2GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4653840-B2 2011-03-16 JP claimed
JP-2009520682-A 2009-05-28 JP claimed
EP-1963362-A1 METASTIN DERIVATIVES AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2008-09-03 EP claimed
WO-2007072997-A1 METASTIN DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-28 WO claimed
EP-2379053-A1 PROPHYLACTIC/THERAPEUTIC AGENT FOR CANCER Takeda Pharmaceutical Company Limited (JP) 2011-10-26 EP disclosed
WO-2010076896-A1 PROPHYLACTIC/THERAPEUTIC AGENT FOR CANCER TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-07-08 WO disclosed
EP-1963362-A1 METASTIN DERIVATIVES AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2008-09-03 EP disclosed
WO-2007072997-A1 METASTIN DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-28 WO disclosed